|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/125 | (2006.01) |
| A61K 39/125 | (2013.01) | ||
| A61K2039/5258 | (2013.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61K2039/55505 | (2013.01) | ||
| A61K2039/55572 | (2013.01) | ||
| A61K2039/70 | (2013.01) | ||
| C12N2770/16034 | (2013.01) | ||
| A61K 39/12 | (2013.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 31/14 | (2018.01) | ||
| A61P 37/04 | (2018.01) |
| (11) | Patento numeris | 3299030 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17199372.8 |
| Europos patento paraiškos padavimo data | 2012-07-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-06-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161506447 P | 2011-07-11 | US |
| (72) |
RICHARDSON, Charles , US
BARGATZE, Robert, F. , US
MENDELMAN, Paul, M. , US
|
| (73) |
Takeda Vaccines, Inc. ,
75 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | PARENTERAL NOROVIRUS VACCINE FORMULATIONS |
| PARENTERAL NOROVIRUS VACCINE FORMULATIONS |